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up to 64 cells, Sox-9 was identified in all cells, along with c-Myc,
nucleostemin and the proteolytic enzymes. RT-PCR confirmed
expression of nucleostemin, c-myc and Sox-9.
Conclusions: Early expression of c-myc may indicate tempo-
rary genomic instability, i.e. a gene expression pattern in flux.
Because nucleostemin is found only in stem cells or cancer, the
presence in clonal chondrocytes is surprising and suggests that
chondrocytes undergo a de-differentiation to a progenitor-like in-
termediate. The re-activation of Sox-9 in late clones suggests
reversion to an earlier chondrocytic differentiation stage. Over-
all, the findings suggest that OA chondrocytes, because they
still retain some chondrocytic characteristics, display a com-
plicated and mixed phenotype, with degradative chondrocytes
arising from a progenitor-cell like intermediate stage, followed
by re-differentiation. At the same time, the observations do not
support the concept of continued differentiation to hypertrophic
chondrocytes.
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Purpose: Osteogenic Protein-1 (OP-1) is a potent growth fac-
tor for cartilage repair due to its pro-anabolic and anti-catabolic
activities. Our goal was to evaluate the role of OP-1 in human
cartilage homeostasis by gene array under conditions of lack
(inhibition of endogenous OP-1 gene by antisense oligos) or ex-
cess of OP-1 (stimulation with recombinant OP-1 [rhOP-1]). This
report is limited to the effect on anabolic genes (growth factors,
regulators of their signaling and matrix proteins) and catabolic
genes (inflammatory cytokines, their receptors, proteinases, and
transcription factors).
Methods: Human normal adult articular cartilage was obtained
from the ankle joints of 12 tissue donors, age 55-70 y/o, within
24 hours of death. After enzymatic digestion chondrocytes were
plated at high-density monolayers and either transfected with
OP-1 antisense oligos in the presence of lipofectin or treated
with rhOP-1 for 48 hours followed by RNA isolation. Gene ex-
pression profile was analyzed by HG-U133A gene chips from
Affimetrix. RNA within each treatment group was pooled from
all donors. Statistical analysis consisted of 1) analysis of differ-
entially expressed genes under single experimental condition in
comparison to control (up- or down-regulated in the presence
of OP-1 antisense or rhOP-1); 2) analysis of differentially regu-
lated genes by both treatments (OP-1 antisense and rhOP-1);
and 3) gene ontology. Selected gene array data were verified
experimentally in vitro or by real-time PCR.
Results: The results showed that the inhibition of endogenous
OP-1 led to down-regulation of a number of anabolic genes
among which were the members of the IGF-1 pathway: IGF-1
receptor (1.73-fold decrease), IGFBP-5 (1.9 fold) and IGFBP-7
(1.58-fold, P<0.01). In vitro validation experiments confirmed and
extended these findings: in chondrocytes treated with OP-1 anti-
sense expression of IGF-1 and its receptor was down-regulated,
while stimulation with rhOP-1 up-regulated their expression. This
in turn restored the response to IGF-1 diminished with aging
of human cartilage. Antisense inhibition of OP-1 reduced gene
expression of the TGF-β/BMP receptors and downstream signal-
ing/regulatory molecules. RhOP-1 inhibited BMP-2 (2.67-fold),
GDF-15 (3.04-fold), and activin (2.32-fold) expression. The fol-
lowing matrix proteins were regulated by OP-1: rhOP-1 induced
collagen type IX, COMP, and cadherin genes; while OP-1 an-
tisense reduced collagen type VI, versican, syndecan, bone
sialoprotein, and other genes. Among catabolic genes the most
affected by OP-1 were leukemia inhibitory factor (LIF), IL-6, IL-8,
IL-11, IL-1 and IL-6 receptors, NF-κB and AP-2. Inhibition of
OP-1 caused a 2-fold increase in their expression (p<0.001),
while treatment with rhOP-1 dramatically inhibited these genes:
LIF by 15.86-fold; IL-6 by 2-fold; IL-8 by 4.0-fold; and IL-11 by
8.69-fold (p<0.001). These changes were confirmed by real-time
PCR. In addition, OP-1 was not only able to reduce gene ex-
pression of autocrine cytokines, but counteracted their inhibitory
effect on proteoglycan synthesis. OP-1 also inhibited MMP-14
and TIMP-3, some caspases, ADAMs and ADAM-TSs.
Conclusions: The initial analysis of gene array data strongly
suggests a critical role of OP-1 in cartilage homeostasis. OP-1
regulates numerous metabolic pathways that are not only limited
to its anabolic function, but also to its anti-catabolic activity.
Understanding of OP-1 function in cartilage will provide strong
justification for the application of OP-1 protein as therapeutic
treatment for cartilage regeneration and repair.
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Purpose: Traumatic injury to a joint is known to increase the
risk of developing secondary osteoarthritis (OA). Various in-vitro
models of injurious loading have been employed to simulate the
effects of joint injury on articular cartilage. The aim of this study
was to compare two of the most common types of pathological
loading models; a single, fast impact load and a slow, severe
load.
Methods: Full depth, circular explants (5 mm diameter) of artic-
ular cartilage were removed from the subchondral bone of two
human femoral heads using a cork borer and scalpel and cul-
tured for 24 h to equilibrate. Explants (n = 24 from each femoral
head), were matched for initial thickness into 3 groups. One
group was subjected to a single, fast impact load using a 500 g
mass dropped from a height of 25 mm in a drop tower. The mean
maximum strain was found and the second group subjected to
loading to the same strain in an Instron materials testing machine
at the fastest available cross-head speed of 40 mm s-1. The third
group served as a control. The modulus was determined from
the maximum gradient of the stress/strain curve for each load.
All explants were then cultured for either 24 h or 72 h. Chondro-
cyte viability was determined in transverse sections (∼500 μm)
using the fluorescein diacetate/propidium iodide method. Frozen
cartilage sections (8 μm) were used to evaluate apoptotic cell
death (TUNEL), matrix damage (haematoxylin and eosin stain),
and glycosaminoglycan (GAG) distribution (toluidine blue stain).
Results: The peak stress of the fast, impact load was 21.7 ±
0.4 MPa and was reached after 1.5 ± 0.1 ms giving a peak
modulus for cartilage of 87.8 ± 13.0 MPa. In comparison, for
slow, severe loading, the peak stress was 0.8 ± 0.2 MPa, with a
duration of 42.4 ± 1.6 ms and a peak modulus of 4.5 ± 1.4 MPa.
Macroscopically, the explants subjected to slow, severe loading
were considerably more damaged than those that were fast im-
pacted; becoming flattened and elliptical in shape with extensive
fissuring. The number of dead cells was also greater with this
type of loading and, after 72 h, only a few viable cells were visible
in the superficial layer. Slow load resulted in about 70% of chon-
drocytes becoming apoptotic by 24 h, and this was unchanged
after 72 h. In contrast, impact loaded explants only had about
10% apoptotic cells (similar to unloaded controls) at 24 h but this
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increased to around 50% after 72 h. Histology confirmed that
slow, severe loading caused considerably more damage than
fast, impact load with the presence of fissuring and uneven GAG
distribution particularly in the deeper zones of the tissue.
Conclusions: Although producing the same strain in the explant,
fast, impact loading was less damaging to cartilage than severe
loading that took almost 30 times longer to reach peak stress.
Induction of apoptosis was more rapid with severe loading al-
though similar levels were reached in both methods after 3 days
in culture. The higher modulus, a measure of resistance to de-
formation, in the fast, impact loading may explain the increased
ability of the cartilage to protect itself from damaging stress lev-
els. The peak stresses reached in the fast, impact loading were
more than 20 times that of the slow, severe load suggesting that
stress alone is not a good indicator of damage.
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Purpose: Degenerative joint disorders such as osteoarthritis
(OA) are associated with pronounced degradation of articular
cartilage and altered synthesis of matrix components in artic-
ular chondrocytes. Inhibition of articular cartilage degeneration
is a priority in the treatment of OA. Oxidative stress can cause
cell death and premature senescence. Aggrecanases and ma-
trix metalloproteinases (MMPs) contribute to the degradation of
extracellular matrix in OA cartilage, while the IGF-1/IGFBP axis
is an important anabolic modulator of cartilage. Several lines of
evidence suggest a cytoprotective role for heme oxygenase-1
(HO-1). In the present work, we have investigated the possible
anabolic and anticatabolic effects of HO-1 induction.
Methods: Cartilage specimens were obtained from 43 patients
with diagnosis of advanced OA undergoing total knee joint re-
placement. Chondrocytes were used in primary culture. Explants
and cells were treated for 6 days or 24 h, respectively, with 100
U/ml IL-1β in the absence or presence of 10 μM of the HO-
1 inducer cobalt protoporphyrin IX (CoPP). Glycosaminoglycan
(GAG) degradation or synthesis was assayed by the release
or incorporation of 35SO42-. Gene expression was assessed by
real time PCR, protein levels by ELISA and western blot, MMPs
activity by fluorometry and oxidative stress by LSC.
Results: CoPP strongly induced HO-1 either in the presence
or absence of IL-1β, whereas IL-1β stimulation of OA chon-
drocytes led to reductions in HO-1 protein and mRNA. HO-1
induction inhibited oxidative stress in IL-1β-stimulated chondro-
cytes. In cartilage explants, HO-1 induction protected against the
degradation of aggrecan, as measured by GAG release. IGF-
1and IGFBP3 production was up-regulated in OA chondrocytes
by HO-1. This was accompanied by a significant increase in
GAG synthesis in chondrocytes. In addition, HO-1 significantly
decreased MMPs activity in supernatants from OA chondrocytes
stimulated with IL-1β. Transfection of chondrocytes with a human
HO-1 siRNA prevented the effects of CoPP.
Conclusions: HO-1 induction controls oxidative stress-related
events linked to the developmentt of OA and exerts a number
of effects relevant for cartilage homeostasis. Therefore, HO-
1 prevents cartilage degradation through the enhancement of
anabolic factors production and proteoglycan synthesis while
suppressing catabolic mediators in OA chondrocytes.
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Purpose: In osteoarthritis (OA) progressive erosion of cartilage
is associated with a phenotypic change to OA chondrocytes
that express proteases and other abnormal genes. This aberrant
expression pattern is thought to be linked to a loss of DNA
methylation in the respective promoters. We hypothesize that OA
chondrocytes produce a factor that diffuses to adjacent normal
chondrocytes where loss of DNA methylation as well as gene
transcription is induced. To test the hypothesis, we selected
MMP-13 and IL-1β and examined the effects of the demethyla-
tion agent 5-aza-deoxycytidine (5-aza-dC) or of co-culture with
superficial-zone OA chondrocytes on normal chondrocytes.
Methods: Cells were isolated from human articular cartilage
obtained, with ethical permission and patients’ consent, from
the femoral heads after arthroplasty for OA or hemi-arthroplasty
following a fracture of the femoral neck (#NOF). The normal
chondrocytes from each #NOF patient were divided into four
groups: non-culture; control culture; culture with 5-aza-dC; co-
culture with OA superficial zone chondrocytes. The cells were
cultured without passaging until reaching confluence (4-5 weeks)
after which RNA and DNA were extracted simultaneously. Real-
time qPCR was used to quantify mRNA expression as well as
the % of methylation at one specific CpG site in each promoter
region (-103 for MMP-13, -289 for IL-1β), which had been shown
to be important in the epigenetic regulation.
Results: In non-cultured chondrocytes from the #NOF patients,
absence of MMP-13 and IL-1β expression correlated with 80-
100% methylation of the CpG sites, as expected. After culture
per se, expression levels had increased slightly and a slight,
but non-significant loss of DNA methylation was recorded. As
expected, culture with 5-aza-dC reduced the % methylation to
20-50%. At the same time the expression of MMP-13 or IL-1β
increased 5-9 fold. The same type of effect was observed after
co-culture with superficial zone OA chondrocytes: A significant
reduction in methylation to 50-70% correlated with a 5-7 fold
increase in gene expression. However, there were variations in
this pattern in different patients: In two cases, loss of methylation
by 5-aza-dC did not induce gene expression and in one case,
induction of gene expression was not associated with loss of
methylation.
Conclusions: Previously, only an association between de-
methylation and abnormal MMP-13 expression had been shown,
here we provide the first direct evidence that gene expression
of MMP-13 and IL-1β in OA is, at least in part, regulated by
DNA methylation, since demethylation by 5-aza-dC resulted in
induction of MMP-13 and IL-1β in normal articular chondrocytes.
The effect was replicated by a factor released from superficial
zone OA chondrocytes, which in vivo might be involved in the
progression of the disease. DNA demethylation is necessary,
but not sufficient for inducing gene expression, the presence
of the right transcription factors is also required. Such factors
may be present in some #NOF patients, but not in others, which
may explain those instances where loss of methylation was not
linked to induction of transcription. On the other hand, it is
feasible that gene expression may be induced in some cases
without changes in methylation status. Nevertheless, we have
shown that loss DNA methy[[Unsupported Character - Code-
name &shy;]]lation plays an important role in the induction of
abnormal gene expression by OA chondrocytes.
